A low antigen dose selectively promotes expansion of high-avidity autoreactive T cells with distinct phenotypic characteristics: A study of human autoreactive CD4+T cells specific for GAD65

References

• Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: Learning self-control in the thymus. Nat Rev Immunol. 2005; 5:772–782.
   PubMed Web of Science ®Google Scholar
• Westerberg LS, Klein C, Snapper SB. Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency—lessons learned from monogenic disorders in mice and men. Curr Opin Immunol. 2008; 20:646–654.
   PubMed Web of Science ®Google Scholar
• Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol. 2003; 21:139–176.
   PubMed Web of Science ®Google Scholar
• Ohashi PS. Negative selection and autoimmunity. Curr Opin Immunol. 2003; 15:668–676.
   PubMedGoogle Scholar
• Parish IA, Heath WR. Too dangerous to ignore: Self-tolerance and the control of ignorant autoreactive T cells. Immunol Cell Biol. 2008; 86:146–152.
   PubMedGoogle Scholar
• Liu GY, Fairchild PJ, Smith RM, Prowle JR, Kioussis D, Wraith DC. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity. 1995; 3:407–415.
   PubMed Web of Science ®Google Scholar
• Zehn D, Bevan MJ. T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity. 2006; 25:261–270.
   PubMed Web of Science ®Google Scholar
• Rees W, Bender J, Teague TK, Kedl RM, Crawford F, Marrack P, Kappler J. An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc Natl Acad Sci USA. 1999; 96:9781–9786.
   PubMed Web of Science ®Google Scholar
• Amrani A, Verdaguer J, Serra P, Tafuro S, Tan R, Santamaria P. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature. 2000; 406:739–742.
   PubMed Web of Science ®Google Scholar
• McHeyzer-Williams LJ, Panus JF, Mikszta JA, McHeyzer-Williams MG. Evolution of antigen-specific T cell receptors in vivo: Preimmune and antigen-driven selection of preferred complementarity-determining region 3 (CDR3) motifs. J Exp Med. 1999; 189:1823–1838.
   PubMed Web of Science ®Google Scholar
• Busch DH, Pamer EG. T cell affinity maturation by selective expansion during infection. J Exp Med. 1999; 189:701–710.
   PubMed Web of Science ®Google Scholar
• Savage PA, Boniface JJ, Davis MM. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity. 1999; 10:485–492.
   PubMed Web of Science ®Google Scholar
• Alexander-Miller MA, Leggatt GR, Berzofsky JA. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci USA. 1996; 93:4102–4107.
   PubMed Web of Science ®Google Scholar
• Alexander-Miller MA, Parker KC, Tsukui T, Pendleton CD, Coligan JE, Berzofsky JA. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes. Int Immunol. 1996; 8:641–649.
   PubMedGoogle Scholar
• Speiser DE, Kyburz D, Stubi U, Hengartner H, Zinkernagel RM. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection. J Immunol. 1992; 149:972–980.
   PubMed Web of Science ®Google Scholar
• Alexander-Miller MA, Leggatt GR, Sarin A, Berzofsky JA. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J Exp Med. 1996; 184:485–492.
   PubMed Web of Science ®Google Scholar
• Mazzanti B, Hemmer B, Traggiai E, Ballerini C, McFarland HF, Massacesi L, Martin R, Vergelli M. Decrypting the spectrum of antigen-specific T-cell responses: The avidity repertoire of MBP-specific T-cells. J Neurosci Res. 2000; 59:86–93.
   PubMedGoogle Scholar
• Chun E, Lee J, Cheong HS, Lee KY. Tumor eradication by hepatitis B virus X antigen-specific CD8+T cells in xenografted nude mice. J Immunol. 2003; 170:1183–1190.
   PubMedGoogle Scholar
• Byers DE, Lindahl KF. Peptide affinity and concentration affect the sensitivity of M3-restricted CTLs induced in vitro. J Immunol. 1999; 163:3022–3028.
   PubMedGoogle Scholar
• Narayan S, Choyce A, Fernando GJ, Leggatt GR. Secondary immunisation with high-dose heterologous peptide leads to CD8 T cell populations with reduced functional avidity. Eur J Immunol. 2007; 37:406–415.
   PubMedGoogle Scholar
• Kim M, Moon HB, Kim K, Lee KY. Antigen dose governs the shaping of CTL repertoires in vitro and in vivo. Int Immunol. 2006; 18:435–444.
   PubMedGoogle Scholar
• Reijonen H, Mallone R, Heninger AK, Laughlin EM, Kochik SA, Falk B, Kwok WW, Greenbaum C, Nepom GT. GAD65-specific CD4+T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. Diabetes. 2004; 53:1987–1994.
   PubMedGoogle Scholar
• Öling V, Marttila J, Ilonen J, Kwok WW, Nepom G, Knip M, Simell O, Reijonen H. GAD65- and proinsulin-specific CD4+T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. J Autoimmun. 2005; 25:235–243.
   PubMedGoogle Scholar
• Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW. Autoreactive T cells in healthy individuals. J Immunol. 2004; 172:5967–5972.
   PubMed Web of Science ®Google Scholar
• Reijonen H, Novak EJ, Kochik S, Heninger A, Liu AW, Kwok WW, Nepom GT. Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes. 2002; 51:1375–1382.
   PubMedGoogle Scholar
• Masewicz SA, Papadopoulos GK, Swanson E, Moriarity L, Moustakas AK, Nepom GT. Modulation of T cell response to hGAD65 peptide epitopes. Tissue Antigens. 2002; 59:101–112.
   PubMed Web of Science ®Google Scholar
• Danke NA, Yang J, Greenbaum C, Kwok WW. Comparative study of GAD65-specific CD4+T cells in healthy and type 1 diabetic subjects. J Autoimmun. 2005; 25:303–311.
   PubMedGoogle Scholar
• Nepom GT. Conversations with GAD. J Autoimmun. 2003; 20:195–198.
   PubMedGoogle Scholar
• Monti P, Scirpoli M, Rigamonti A, Mayr A, Jaeger A, Bonfanti R, Chiumello G, Ziegler AG, Bonifacio E. Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes. J Immunol. 2007; 179:5785–5792.
   PubMed Web of Science ®Google Scholar
• Novak EJ, Liu AW, Nepom GT, Kwok WW. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J Clin Invest. 1999; 104:R63–R67.
   PubMed Web of Science ®Google Scholar
• Reichstetter S, Ettinger RA, Liu AW, Gebe JA, Nepom GT, Kwok WW. Distinct T cell interactions with HLA class II tetramers characterize a spectrum of TCR affinities in the human antigen-specific T cell response. J Immunol. 2000; 165:6994–6998.
   PubMedGoogle Scholar
• Zeh HJ3rd, Perry-Lalley D, Dudley ME, Rosenberg SA, Yang JC. High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. J Immunol. 1999; 162:989–994.
   PubMed Web of Science ®Google Scholar
• Gallimore A, Dumrese T, Hengartner H, Zinkernagel RM, Rammensee HG. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J Exp Med. 1998; 187:1647–1657.
   PubMed Web of Science ®Google Scholar
• Bullock TN, Mullins DW, Engelhard VH. Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+T cells. J Immunol. 2003; 170:1822–1829.
   PubMed Web of Science ®Google Scholar
• Oh S, Hodge JW, Ahlers JD, Burke DS, Schlom J, Berzofsky JA. Selective induction of high avidity CTL by altering the balance of signals from APC. J Immunol. 2003; 170:2523–2530.
   PubMed Web of Science ®Google Scholar
• Kroger CJ, Amoah S, Alexander-Miller MA. Cutting edge: Dendritic cells prime a high avidity CTL response independent of the level of presented antigen. J Immunol. 2008; 180:5784–5788.
   PubMed Web of Science ®Google Scholar
• Kedl RM, Rees WA, Hildeman DA, Schaefer B, Mitchell T, Kappler J, Marrack P. T cells compete for access to antigen-bearing antigen-presenting cells. J Exp Med. 2000; 192:1105–1113.
   PubMed Web of Science ®Google Scholar
• Casanova JL, Romero P, Widmann C, Kourilsky P, Maryanski JL. T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: Implications for T cell allelic exclusion and antigen-specific repertoire. J Exp Med. 1991; 174:1371–1383.
   PubMed Web of Science ®Google Scholar
• Laugel B, van den Berg HA, Gostick E, Cole DK, Wooldridge L, Boulter J, Milicic A, Price DA, Sewell AK. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J Biol Chem. 2007; 282:23799–23810.
   PubMedGoogle Scholar
• Rubio-Godoy V, Dutoit V, Rimoldi D, Lienard D, Lejeune F, Speiser D, Guillaume P, Cerottini JC, Romero P, Valmori D. Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life. Proc Natl Acad Sci USA. 2001; 98:10302–10307.
   PubMedGoogle Scholar
• Lyons GE, Roszkowski JJ, Man S, Yee C, Kast WM, Nishimura MI. T-cell receptor tetramer binding or the lack there of does not necessitate antigen reactivity in T-cell receptor transduced T cells. Cancer Immunol Immunother. 2006; 55:1142–1150.
   PubMedGoogle Scholar
• Quarsten H, McAdam SN, Jensen T, Arentz-Hansen H, Molberg O, Lundin KE, Sollid LM. Staining of celiac disease-relevant T cells by peptide-DQ2 multimers. J Immunol. 2001; 167:4861–4868.
   PubMed Web of Science ®Google Scholar
• Kedzierska K, La Gruta NL, Stambas J, Turner SJ, Doherty PC. Tracking phenotypically and functionally distinct T cell subsets via T cell repertoire diversity. Mol Immunol. 2008; 45:607–618.
   PubMedGoogle Scholar
• de Waal Malefyt R, Abrams JS, Zurawski SM, Lecron JC, Mohan-Peterson S, Sanjanwala B, Bennett B, Silver J, de Vries JE, Yssel H. Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol. 1995; 7:1405–1416.
   PubMedGoogle Scholar
• Zurawski G, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today. 1994; 15:19–26.
   PubMedGoogle Scholar
• Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ. Human IL-17: A novel cytokine derived from T cells. J Immunol. 1995; 155:5483–5486.
   PubMed Web of Science ®Google Scholar
• Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity. 2004; 21:467–476.
   PubMed Web of Science ®Google Scholar
• Lubberts E, Koenders MI, van den Berg WB. The role of T-cell interleukin-17 in conducting destructive arthritis: Lessons from animal models. Arth Res Ther. 2005; 7:29–37.
   PubMed Web of Science ®Google Scholar
• Murugaiyan G, Mittal A, Weiner HL. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J Immunol. 2008; 181:7480–7488.
   PubMed Web of Science ®Google Scholar
• Adorini L, Guery JC, Trembleau S. Manipulation of the Th1/Th2 cell balance: An approach to treat human autoimmune diseases?. Autoimmunity. 1996; 23:53–68.
   PubMed Web of Science ®Google Scholar
• Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+T cell responses: The alternative approaches. Annu Rev Immunol. 1997; 15:297–322.
   PubMed Web of Science ®Google Scholar
• La Gruta NL, Turner SJ, Doherty PC. Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+T cell responses: Correlation of cytokine profile and TCR avidity. J Immunol. 2004; 172:5553–5560.
   PubMed Web of Science ®Google Scholar
• Pfeiffer C, Murray J, Madri J, Bottomly K. Selective activation of Th1- and Th2-like cells in vivo-response to human collagen IV. Immunol Rev. 1991; 123:65–84.
   PubMedGoogle Scholar
• Murray JS, Madri J, Pasqualini T, Bottomly K. Functional CD4 T cell subset interplay in an intact immune system. J Immunol. 1993; 150:4270–4276.
   PubMedGoogle Scholar
• Constant S, Pfeiffer C, Woodard A, Pasqualini T, Bottomly K. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+T cells. J Exp Med. 1995; 182:1591–1596.
   PubMed Web of Science ®Google Scholar
• Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, Peakman M. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest. 2004; 113:451–463.
   PubMed Web of Science ®Google Scholar
• Im JS, Quinn A, Sercarz EE, Lake DF. Molecular profile of the T cell receptors of regulatory and effector CD4+T cells recognizing overlapping determinants on glutamic acid decarboxylase (524–543). Mol Immunol. 2004; 40:971–980.
   PubMedGoogle Scholar
• Tarbell KV, Lee M, Ranheim E, Chao CC, Sanna M, Kim SK, Dickie P, Teyton L, Davis M, McDevitt H. CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer. J Exp Med. 2002; 196:481–492.
   PubMed Web of Science ®Google Scholar